Growth Metrics

Docebo (DCBO) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for Docebo (DCBO) over the last 7 years, with Q3 2025 value amounting to 9.77%.

  • Docebo's EBITDA Margin fell 5500.0% to 9.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.83%, marking a year-over-year decrease of 9700.0%. This contributed to the annual value of 10.79% for FY2024, which is 72200.0% up from last year.
  • Per Docebo's latest filing, its EBITDA Margin stood at 9.77% for Q3 2025, which was down 5500.0% from 6.99% recorded in Q2 2025.
  • Docebo's EBITDA Margin's 5-year high stood at 16.24% during Q1 2021, with a 5-year trough of 5.33% in Q4 2021.
  • Moreover, its 5-year median value for EBITDA Margin was 8.31% (2024), whereas its average is 7.29%.
  • The largest annual percentage gain for Docebo's EBITDA Margin in the last 5 years was 354500bps (2021), contrasted with its biggest fall of -25325200bps (2021).
  • Over the past 5 years, Docebo's EBITDA Margin (Quarter) stood at 5.33% in 2021, then soared by 100bps to 0.01% in 2022, then skyrocketed by 193877bps to 12.69% in 2023, then grew by 27bps to 16.07% in 2024, then crashed by -39bps to 9.77% in 2025.
  • Its last three reported values are 9.77% in Q3 2025, 6.99% for Q2 2025, and 2.56% during Q1 2025.